GGrantIndex
Sort

34,240 grants matching atherosclerosis

A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers

$1,925,025
Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2013 · HL

DNA virus as vectors for cardiovascular diseases

$1,925,010
James M Wilson · University Of Pennsylvania · P01 · FY2006 · HL

Late-life trajectories of cardiac function to define pathways of cardiac resilience

$1,924,088
Amil M Shah · Ut Southwestern Medical Center · R01 · FY2025 · HL

LIPOPROTEIN METABOLISM IN ATHEROSCLEROSIS

$1,923,785
Wake Forest University Health Sciences · P01 · FY2002 · HL

Structural and Cell Biology in Cardiovascular Disease

$1,923,352
David Atkinson · Boston University Medical Campus · P01 · FY2006 · HL

The Strong Heart Study, Phase V

$1,922,549
Elisa Lee · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2010 · HL

CRITICAL TRANSITIONS IN ATHEROGENESIS

$1,921,660
Brigham And Women'S Hospital · P50 · FY2005 · HL

DNA virus as vectors for cardiovascular diseases

$1,920,797
University Of Pennsylvania · P01 · FY2005 · HL

Immune Cells in Atherosclerosis and Vascular Disease

$1,920,669
Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2015 · HL

CARDIA

$1,920,500
Stephen Sidney · Kaiser Foundation Research Institute · N01 · FY2011 · HL

PPG - Oxidative Mechanisms in Vascular Disease

$1,918,557
Donald D Heistad · University Of Iowa · P01 · FY2010 · HL

DNA virus as vectors for cardiovascular diseases

$1,918,557
James M Wilson · University Of Pennsylvania · P01 · FY2007 · HL

HUMAN LIPOPROTEIN PATHOPHYSIOLOGY

$1,918,273
John J Albers · University Of Washington · P01 · FY2008 · HL

Molecular Mechanisms of Arterigenesis

$1,917,856
Michael Simons · Yale University · P01 · FY2021 · HL

Biology and Novel Therapeutics of Cardiovascular Peptides

$1,916,871
John C Burnett · Mayo Clinic Rochester · P01 · FY2012 · HL

Protective Mechanisms In Cerebral Ischemia

$1,916,017
John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS

SCCOR in Metabolic Syndrome and Vascular Disease

$1,914,867
Clay F. Semenkovich · Washington University · P50 · FY2008 · HL

Stroke, Cognition and Neuroepidemiology Section

$1,914,733
Rebecca F Gottesman · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS

BIOBEHAVIORAL BASES OF CHD RISK AND MANAGEMENT

$1,914,438
University Of Miami Coral Gables · P01 · FY2003 · HL

Immune Cells in Atherosclerosis and Vascular Disease

$1,914,297
Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2014 · HL

MECHANISMS OF CARDIOVASCULAR REACTION TO INJURY

$1,914,231
University Of Washington · P01 · FY2003 · HL

Molecular Mechanisms of Arterigenesis

$1,913,890
Michael Simons · Yale University · P01 · FY2019 · HL

Molecular Mechanisms of Arterigenesis

$1,912,161
Michael Simons · Yale University · P01 · FY2022 · HL

Molecular Mechanisms of Arterigenesis

$1,911,829
Michael Simons · Yale University · P01 · FY2020 · HL

Glucose, Insulin in Diabetic Vascular Disease

$1,907,646
University Of Virginia Charlottesville · P01 · FY2003 · HL